To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
This study has been terminated.
(The study was stopped due to insufficient enrollment.)
Information provided by:
First received: November 5, 2009
Last updated: January 14, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||January 2011 (Final data collection date for primary outcome measure)|